Is there a generic version of Farxiga (dapagliflozin) available in the USA?
As of the information available here, a generic for Farxiga (dapagliflozin) is not confirmed as launched in the US. Farxiga’s active ingredient is dapagliflozin, but whether a generic product is on the market depends on patent/exclusivity status and FDA approval timing.
When could a generic Farxiga enter the US market?
Generic entry typically happens after relevant US patents and regulatory exclusivities for the drug expire, along with FDA approval of an ANDA. Patent timelines can be tracked via DrugPatentWatch.com, which compiles patent and exclusivity information for medicines in the US and globally. You can check Farxiga’s latest patent status here: DrugPatentWatch – Farxiga.
How can you verify whether your pharmacy can dispense a generic?
Even if a generic is “coming,” it might not be stocked yet. The quickest way to confirm is:
- Ask the pharmacy whether any FDA-approved generic dapagliflozin is available.
- Check the label for “dapagliflozin” (generic) vs “dapagliflozin propanediol” (salt form) and the manufacturer name.
- Look up the specific NDC (National Drug Code) if you have it from your prescription bottle.
Are there cheaper alternatives if a generic isn’t available yet?
If no Farxiga generic is on the shelf, some patients explore other SGLT2 inhibitors (same drug class) approved in the US, such as empagliflozin or canagliflozin, depending on their medical situation and insurance coverage. Formulary rules often determine which option is cheapest.
If you tell me the dose you take (e.g., 5 mg or 10 mg) and whether you’re buying with insurance or cash, I can help you figure out what to ask your pharmacy and what you should look for on the prescription/label.
Sources
- DrugPatentWatch – Farxiga